Abbott LaboratoriesvsPuma Biotechnology

ABT and PBYI stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.64

Value $182B

+0.26%
ABT's page

PBYI

Puma Biotechnology Inc

$7.14

Value $363M

-1.11%
PBYI's page

Abbott Laboratories (ABT) has a market value of $182B and Puma Biotechnology (PBYI) $363M. Over the last year, with dividends, ABT moved -17.5% and PBYI +41.1%. The P/E is 38.7 for ABT and 15.2 for PBYI. Dividend yield: ABT 2.41%, PBYI none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    PBYI$363M

    ABT is 501 times PBYI

  • Revenue, 12 months

    ABT$48.2B

    PBYI$232M

    ABT is 208 times PBYI

  • Net income, 12 months

    ABT$4.7B

    PBYI$24M

    ABT is 197 times PBYI

  • Operating margin

    ABT13.8%

    PBYI11.3%

    2.5 points apart

  • ROIC

    ABT6.3%

    PBYI12.8%

    6.5 points apart

  • P/E

    ABT38.7

    PBYI15.2

    ABT is 2.5 times PBYI

  • Dividend yield

    ABT2.4%

    PBYI0.0%

    2.4 points apart

  • 5-year return

    ABT-9.4%

    PBYI+111.9%

    121.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-9.4%

PBYI+112.0%

10020030020222023202420252026
Returns by period
PeriodABTWith dividendsPBYIWith dividends
1 year since November 18, 2025-17.5%Price -19.5%+41.1%Price +41.1%
3 years since November 17, 2023+12.0%+3.9% a yearPrice +5.2%+85.5%+22.9% a yearPrice +85.5%
5 years since November 18, 2021-9.4%-2.0% a yearPrice -18.0%+111.9%+16.2% a yearPrice +111.9%
10 years since November 21, 2016+217.7%+12.3% a yearPrice +163.3%-83.7%-16.6% a yearPrice -83.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesPBYIPuma Biotechnology

Valuation

ABTPBYI
Valuation
Price$104.64$7.14
Market value$182B$363M
Enterprise value (EV)$209B$308M
P/E38.715.2
P/E, 5-year median33.79.6
P/B3.62.5
EV/EBIT31.411.8
Free cash flow yield3.7%12.7%

Results and growth

ABTPBYI
Results and growth
Revenue, 12 months$48.2B$232M
Net income, 12 months$4.7B$24M
Free cash flow, 12 months$6.8B$46M
Earnings per share, 12 months$2.69$0.46
Revenue growth, year on year5.7%-0.9%
Revenue growth a year, past+5.1%over 5 years+0.3%over 5 years
EPS growth a year, past+8.3%over 5 years–

Margins and returns on capital

ABTPBYI
Margins and returns on capital
Gross margin56.9%73.6%
Operating margin13.8%11.3%
Net margin9.8%10.3%
ROIC6.3%12.8%
ROE9.1%18.1%

Balance sheet

ABTPBYI
Balance sheet
Cash$4.3B$101M
Total debt$31.2B$50M
Net debt / EBITDA3.3-1.5
Interest cover6.7×12.9×

Dividends and buybacks

ABTPBYI
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or PBYI

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Puma Biotechnology?

By market value, Abbott Laboratories ($182B) is about 500.6 times Puma Biotechnology ($363M), at today's prices.

How did ABT and PBYI stock do over the last 10 years?

Since November 21, 2016, ABT's price moved +163.3% and PBYI's -83.7%. With dividends: ABT +217.7% (+12.3% a year), PBYI -83.7% (-16.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or PBYI?

The dividend yield at today's price is 2.41% for Abbott Laboratories and none for Puma Biotechnology. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and PBYI?

At today's price, the P/E is 38.7 for ABT and 15.2 for PBYI. The median of the last five years was 33.7 and 9.6, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Puma Biotechnology?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 10.3% for Puma Biotechnology, and the operating margin 13.8% and 11.3%. Revenue was $48.2B and $232M.

Which is the better investment, Abbott Laboratories or Puma Biotechnology?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.